Peptides DB
Research-centric peptide and protocol reference hub
Study 29 of 35LL-37 literatureCurrent eye research · Observational2005

Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.

LL-37 is expressed in ocular surface epithelia and shows significant antibacterial and antiviral activity in vitro, but further research is needed to confirm its clinical relevance.

Read at Current eye researchAdd to compare

Where it sits

this study against the rest of the ll-37 corpus
6
Preclinical
20
Observational · this one
0
Open-label
5
Randomised
4
Reviews

Summary and findings

This study measured the expression of LL-37 in human conjunctival and corneal epithelia and assessed its antibacterial and antiviral activity. LL-37 was expressed by these epithelial cells, and its antibacterial activity was evaluated against various pathogens. The study found LL-37 to have significant antimicrobial properties in vitro.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
EC50 values for three strains of Pseudomonas aeruginosa were 2.8 +/- 1.3, 1.9 +/- 0.3, and 3.6 +/- 2.1 microg/ml.2005

Abstract

The authors’ words, as Current eye research supplied them

<h4>Purpose</h4>This study determined whether LL-37 (cathelicidin) is expressed by conjunctival and corneal epithelia as part of ocular host defense. The antimicrobial activity of LL-37 was also assessed in vitro against Pseudomonas aeruginosa (PA), Staphylococcus aureus (SA), Staphylococcus epidermidis (SE), herpes simplex virus type 1 (HSV-1), and adenovirus (Ad).<h4>Methods</h4>Expression of LL-37/hCAP 18 mRNA and LL-37 protein was determined by reverse transcription-polymerase chain reaction (RT-PCR) and immunoblotting, respectively, in scraped human corneal epithelium and primary cultured human corneal and conjunctival epithelial cells. The EC50 values for three strains of PA and one each of SA and SE were determined for LL-37. LL-37 antiviral inhibition of HSV-1 and adenovirus was assessed by direct inactivation assays. Toxicity of LL-37 to A549 cells was evaluated by a MTT assay.<h4>Results</h4>LL-37/hCAP18 mRNA and LL-37 peptide were expressed by human corneal and conjunctival epithelial cells. Antibacterial activity for LL-37 was demonstrated (EC50 values for the three PA strains were 2.8 +/- 1.3, 1.9 +/- 0.3, and 3.6 +/- 2.1; for SA: 1.6 +/- 1.5; for SE: 1.3 +/- 1.9 microg/ml). LL-37 produced a significant reduction (p < 0.001 ANOVA) in HSV-1 and Ad19 viral titers with distinctly different time-kill curves (p < 0.001). LL-37 (up to 111 microM) produced no toxicity in A549 cells.<h4>Conclusions</h4>Corneal and conjunctival epithelia express LL-37 as part of mucosal innate immunity to protect against bacterial and viral ocular infections.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the LL-37 corpus

CAge-Dependent Effects of Macrophage Derived Cathelicidin Antimicrobial Peptide on Bone Fracture Repairbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCA koala pangenome reveals hidden structural variation with implications for disease and fertilitybiorxiv-preprint · 2026 · n=13 · Approximately 193,000 SVs identified.AnimalCLL-37 and Citrullinated-LL-37 elicited Transcriptome and Cytokine Profiles in Human Bronchial Epithelial Cells: Citrullination dampens the inflammatory biosignaturebiorxiv-preprint · 2026 · Inflammatory response was significantly less (by ∼45%) with citLL-37 compared to LL-37.In vitroCValorisation of invasive North Sea macroalgae as functional feed additives to improve disease resilience in Pacific white shrimp (Litopenaeus vannamei)biorxiv-preprint · 2026 · Survival increased from 60.00 ± 12.02% in the control to 74.44 ± 8.39% in the seaweed-supplemented group.AnimalBAn audit assessing data quality, viral suppression, and transition to dolutegravir among children and adolescents with HIV in care at eThekwini Municipality, South Africabiorxiv-preprint · 2026 · 10% had a last VL ≥1000 copies/mL.HumanDCoarse composition suffices: tabular in-context learning for multi-activity antimicrobial peptide profilingbiorxiv-preprint · 2026 · mAP-5=77.8% on ESCAPE benchmark, n=82,359 peptides.review